Overview

Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation

Status:
Completed
Trial end date:
2011-08-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to identify and validate a probe cocktail for use in future drug-drug interaction studies. Cytochrome P450 enzymes and transport proteins play important roles in the disposition of drugs. Changes in the activity of these pathways can be assessed using probe drugs selected on the basis of their metabolic or transport pathway. This will be a two part study with the same subjects participating in both parts to decrease variability in data. The purpose of Part 1 is to identify a set of probe drugs ('cocktail') which do not interact with one another; groups of healthy volunteers will receive 7 probe drugs individually and as a combination of the 7 drugs given together as a cocktail. Part 2 will assess the performance of the probe cocktail using three known inhibitors (validation). The inhibitors plus probe cocktail will evaluate the ability of the newly established cocktail to accurately quantify metabolizing enzyme or transporter inhibition, representing a fundamental advance in probe cocktail validation and utility for drug development.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Caffeine
Dextromethorphan
Fluconazole
Flurbiprofen
Ketoconazole
Midazolam
Omeprazole
Pioglitazone
Rifampin
Rosiglitazone
Rosuvastatin Calcium